| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | Berlin, Bonn, Hannover | ohne Phasenangabe | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Ahrensburg, Bamberg, Berlin | Phase III | rekrutiert |
| A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Ge | Bonn, Göttingen, Hannover | Phase II | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Bad Oeynhausen, Berlin, Brandenburg an der Havel | Phase III | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Aachen, Berlin, Frankfurt am Main | Phase I / Phase II | rekrutiert |
| A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodi | Bonn, Köln, Hamburg | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Gießen, Hamburg, Hannover | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Berlin, Essen, Frankfurt am Main | Phase III | rekrutiert |
| A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treat | Amberg, Bielefeld, Dresden | Phase III | rekrutiert |
| A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:T | Hannover, Essen, Halle (Saale) | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Aachen, Berlin, Dachau | Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | Ulm, Frankfurt am Main, Hannover | — | rekrutiert |
| A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Hannover, Heidelberg, Homburg | Phase I / Phase II | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Augsburg, Berlin, Brandenburg an der Havel | Phase II | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Berlin, Dachau, Erlangen | Phase II / Phase III | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Esslingen am Neckar, Augsburg, München | Phase II / Phase III | rekrutiert |
| A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neop | Aachen, Berlin, Essen | Phase I | rekrutiert |
| A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and | Gießen, Hannover, Jena | Phase III | rekrutiert |
| A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hyperten | Hannover | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Aachen, Köln, Dresden | Phase III | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | Bamberg, Bonn, Köln | — | rekrutiert |
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradi | Mannheim, Ulm, Marburg | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | München, Hannover, Chemnitz | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Leipzig, Aachen, Berlin | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Mar | Würzburg, Münster, Jena | Phase III | rekrutiert |
| A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Childre | Berlin, Hamburg, Hannover | Phase III | rekrutiert |
| A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic P | Essen, Hannover | Phase II | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Berlin, Köln, Hamburg | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Freiburg im Breisgau, Ulm, Würzburg | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Fa | Essen, Hannover, Immenhausen | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Berlin, Bonn, Braunschweig | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Bad Bramstedt, Berlin, Dresden | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Bad Friedrichshall, Bamberg, Berlin | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Aachen, Bad Friedrichshall, Berlin | Phase III | rekrutiert |
| A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis De | Frankfurt am Main, Rostock, Düsseldorf | Phase III | rekrutiert |
| ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants Wi | Heidelberg, München, Hannover | Phase II | rekrutiert |
| Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma | Hannover | Phase I / Phase II | rekrutiert |
| An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) | Hannover, Frankfurt am Main | Phase II | rekrutiert |
| Chronic Outcome Monitoring for DBS in Dystonia | Hannover, Düsseldorf, Berlin | — | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Aachen, Augsburg, Berlin | Phase II | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Aachen, Bonn, Köln | Phase II | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Aachen, Bad Kreuznach, Bad Nenndorf | Phase III | rekrutiert |
| Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Poly | Berlin, Bochum, Halle (Saale) | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Berlin, Brandenburg an der Havel, Erlangen | Phase II | rekrutiert |
| Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia ( | Berlin, Essen, Freiburg im Breisgau | Phase III | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Aachen, Augsburg, Bergisch Gladbach | Phase III | rekrutiert |
| European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Bi | Hannover | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Stuttgart, Tübingen, Winnenden | Phase II | rekrutiert |
| Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the | Hannover, Leipzig | Phase II | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | Frankfurt am Main, Aachen, Altenburg | — | rekrutiert |
| Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis | Hannover | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Aachen, Augsburg, Bad Saarow | Phase III | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Augsburg, Berlin, Bonn | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | Aachen, Augsburg, Berlin | — | rekrutiert |
| JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | Gießen, Hannover, Jena | Phase III | rekrutiert |
| Long-term Follow-up of Children Born in the PETN Studies | Tübingen, Ulm, München | — | rekrutiert |
| Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Follo | Heidelberg, Gießen, Hannover | — | rekrutiert |
| Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately t | Frankfurt am Main, Grevenbroich, Halle (Saale) | Phase III | rekrutiert |
| Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Activ | Frankfurt am Main, Grevenbroich, Halle (Saale) | Phase III | rekrutiert |
| PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different | Berlin, Köln, Hamburg | Phase II | rekrutiert |
| Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Mali | Ulm, München, Würzburg | Phase I | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Heidelberg, Nürtingen, München | Phase II / Phase III | rekrutiert |
| Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in | Berlin, Halle (Saale), Hannover | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Aschaffenburg, Bad Saarow, Berlin | Phase III | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Amberg, Bad Saarow, Bayreuth | Phase III | rekrutiert |
| Prospective WCD Post CABG Registry (CABG Registry) | Bad Nauheim, Hannover, Cottbus - Chóśebuz | — | rekrutiert |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | Berlin, Düsseldorf, Gießen | ohne Phasenangabe | rekrutiert |
| Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care A | Augsburg, Bad Saarow, Bochum | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Aachen, Aschaffenburg, Augsburg | Phase II | rekrutiert |
| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Cou | Aachen, Berlin, Köln | Phase IV | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | Berlin, Bochum, Köln | — | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | Altdorf, Augsburg, Bad Windsheim | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | Aschaffenburg, Augsburg, Aurich | — | rekrutiert |
| Registry for Patients With X-Linked Hypophosphatemia | Bad Belzig, Bochum, Köln | — | rekrutiert |
| Registry of Patients Having Received oNKord® | Hannover | — | rekrutiert |
| Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, | Hannover, Jena | — | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Stuttgart, Nürnberg, Aachen | Phase III | rekrutiert |
| Safe and Timely Antithrombotic Removal (STAR) Registry | Coswig, Erlangen, Essen | — | rekrutiert |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematol | Köln, Hannover, Mainz | Phase I / Phase II | rekrutiert |
| Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Bre | Bayreuth, Köln, Dresden | Phase I / Phase II | rekrutiert |
| Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus | Hannover | Phase I / Phase II | rekrutiert |
| Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative C | Berlin, Hannover, Kiel | Phase II | rekrutiert |
| Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary | Rosenheim, Hannover, Bad Berka | Phase III | rekrutiert |
| Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bul | Düsseldorf, Frankfurt am Main, Hannover | Phase II / Phase III | rekrutiert |
| TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study | Gauting, Regensburg, Harburg (Schwaben) | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Aachen, Amberg, Berlin | Phase III | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Aachen, Ahrensburg, Bamberg | Phase III | rekrutiert |
| The German ADPKD Tolvaptan Treatment Registry | Müllheim im Markgräflerland, Würzburg, Hannover | — | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | München, Würzburg, Frankfurt am Main | Phase III | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | München, Würzburg, Jena | Phase II | rekrutiert |
| Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Ad | Leipzig, Hannover, Berlin | ohne Phasenangabe | rekrutiert |
| Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunothe | Göttingen, Hannover, Oldenburg | — | rekrutiert |
| Valved Graft PMCF Study | Bad Oeynhausen, Berlin, Bremen | — | rekrutiert |
| tTF-NGR Randomized Study - STS | Bad Saarow, Berlin, Dresden | Phase III | rekrutiert |